Insulet Corporation (PODD)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$6.96 (+2.63%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of Insulet Corporation (PODD)
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.

Key Insights

Critical company metrics and information
  • Share Price

    $272.79
  • Market Cap

    $19.13 Billion
  • Total Outstanding Shares

    70.15 Million Shares
  • Total Employees

    3,000
  • Dividend

    No dividend
  • IPO Date

    May 15, 2007
  • SIC Description

    Surgical & Medical Instruments & Apparatus
  • Homepage

    https://www.insulet.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow From Investing Activities, Continuing$-109.80 Million
Net Cash Flow From Operating Activities, Continuing$327.80 Million
Net Cash Flow, Continuing$213.00 Million
Net Cash Flow From Financing Activities$-5.00 Million
Net Cash Flow From Investing Activities$-109.80 Million
Net Cash Flow From Operating Activities$327.80 Million
Net Cash Flow From Financing Activities, Continuing$-5.00 Million
Exchange Gains/Losses$4.20 Million
Net Cash Flow$217.20 Million

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Benefits Costs and Expenses$1.69 Billion
Selling, General, and Administrative Expenses$869.00 Million
Net Income/Loss Attributable To Parent$420.90 Million
Costs And Expenses$1.69 Billion
Gross Profit$1.38 Billion
Basic Average Shares$70.08 Million
Net Income/Loss$420.90 Million
Diluted Average Shares$77.35 Million
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Income/Loss From Continuing Operations Before Tax$296.70 Million
Income/Loss From Continuing Operations After Tax$420.90 Million
Net Income/Loss Available To Common Stockholders, Basic$420.90 Million
Basic Earnings Per Share$6.02
Research and Development$201.00 Million
Revenues$1.98 Billion
Income Tax Expense/Benefit$-124.20 Million
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Diluted Earnings Per Share$5.87
Preferred Stock Dividends And Other Adjustments$0.00
Operating Income/Loss$306.00 Million
Operating Expenses$1.07 Billion
Cost Of Revenue$607.90 Million

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Equity Attributable To Parent$1.12 Billion
Equity Attributable To Noncontrolling Interest$0.00
Accounts Payable$40.30 Million
Assets$3.03 Billion
Current Liabilities$506.20 Million
Current Assets$1.86 Billion
Other Current Liabilities$465.90 Million
Liabilities And Equity$3.03 Billion
Other Current Assets$1.42 Billion
Noncurrent Assets$1.16 Billion
Inventory$444.90 Million
Noncurrent Liabilities$1.40 Billion
Equity$1.12 Billion
Liabilities$1.91 Billion

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.